Long-standing interest in cancer research with a special focus on tumor microenvironment and cancer immunotherapy. We use different types of pre-clinical models including patient-derived tumor organoids trying to understand mechanisms of therapy resistance to current and novel treatment. In close cooperation with groups from computational biology and mathematics we aim at establishing novel approaches and models to analyze and simulate tumor and immune cell phenotype dynamics in the tumor microenvironment under immunotherapy.